Ontology highlight
ABSTRACT:
SUBMITTER: Lehmann F
PROVIDER: S-EPMC2960986 | biostudies-literature | 2008 Mar
REPOSITORIES: biostudies-literature
Acta crystallographica. Section E, Structure reports online 20080312 Pt 4
The crystal structure of the title compound, C(25)H(18)ClN(5)O, was determined in the course of our studies on the synthesis of 1,4-dihydro-pyrano[2,3-c]pyrazole as an inhibitor of the p38 mitogen-activated protein kinase (MAPK). The compound was prepared via a base-catalysed synthesis from 1-benzyl-3-(4-pyrid-yl)-1H-pyrazol-5(4H)-one with p-chloro-aldehyde and malononitrile. The crystal data obtained were used to generate a three-dimensional pharmacophore model for in silico database screening. ...[more]